Rani Therapeutics Holdings Inc. (RANI)
NASDAQ · Healthcare
Rani Therapeutics Holdings Inc. Shareholder Equity 2020–2025
Rani Therapeutics Holdings Inc. annual shareholder equity history from 2020 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Rani Therapeutics Holdings Inc. shareholder equity as of December 31, 2025: 33.0M, a 1557.13% increase year-over-year.
- Rani Therapeutics Holdings Inc. shareholder equity for 2025 were 33.0M, a 1557.13% increase from 2024.
- Rani Therapeutics Holdings Inc. shareholder equity for 2024 were 2.0M, a 84.52% decrease from 2023.
- Rani Therapeutics Holdings Inc. shareholder equity for 2023 were 12.9M, a 65.09% decrease from 2022.
- Rani Therapeutics Holdings Inc. shareholder equity for 2022 were 36.9M.
Shareholder Equity
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Rani Therapeutics Holdings Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $33 |
| 2024 | $2 |
| 2023 | $13 |
| 2022 | $37 |
| 2021 | $47 |
| 2020 | $-113 |
Rani Therapeutics Holdings Inc. Shareholder Equity — FAQ
Rani Therapeutics Holdings Inc. (RANI) shareholder equity over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see RANI's shareholder equity history?
The chart and table above show Rani Therapeutics Holdings Inc.'s shareholder equity by year and by quarter, including the growth rate.